EMERGENT BIOSOLUTIONS INC revenue for the last year amounted to 950.68 M EUR, the most of which — 450.56 M EUR — came from its highest performing source at the moment, Commercial Products. The greatest contribution to the revenue figure was made by United States — last year it brought EMERGENT BIOSOLUTIONS INC 550.13 M EUR, and the year before that — 831.11 M EUR.